Overall Technical outlook

Price Summary

On 2025-04-25, APLLTD's stock started at 880.0, reached a high of 895.0, fell to 855.15, and ended -0.52% lower at 875.45, with 134690 shares traded.
In the last 52 weeks, the stock's top price was 1247.7 and the bottom price was 743.65.
The future price of APLLTD is anticipated to range from 909.0 to 1411.0, with an expected mean price of 1054.6364, according to the recommendations of 11 analysts.

Technicals

Support and Resistance: The price for APLLTD at 875.45 finds support at 844.65 and resistance at 898.3. This suggests a trading range, where 844.65 serves as a support level and 898.3 acts as a resistance point, potentially capping further gains.
APLLTD supportResistance 2789ad
Support/Resistance for APLLTD


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
APLLTD aroon 2789ad
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
APLLTD bbands 2789ad
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish in its outlook, establishing a key support level that could serve as a foundation for further upward movement. This persistent bullish stance suggests that the market may continue to trend higher, with the established support providing a potential safety net for investors.
APLLTD psar 2789ad
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The STOCHASTIC is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
APLLTD stoch 2789ad
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
APLLTD trippleSMA 2789ad
Tripple SMA chart for Alembic Pharmaceuticals Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.